Methyl-CpG-binding domain 3 inhibits epithelial–mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling

Background:Methyl-CpG-binding domain 3 (MBD3) is an aberrant expression in human malignancies. However, the role of MBD3 in pancreatic cancer progression remains to be clarified. In this study, we investigated the effects of MBD3 on the epithelial–mesenchymal transition (EMT), and the underlying mechanism in pancreatic cancer cells.Methods:The abilities of migration and invasion were examined by transwell and BD Matrigel invasion assays. EMT and TGF-β/Smad signalling were evaluated.Results:First, we find that MBD3 expression is lower in pancreatic cancer tissues than that in non-tumour tissues, and patients with lower MBD3 levels survive significantly less than those with higher levels. Subsequently, we find that MBD3 knockdown promotes the abilities of migration and invasion, while MBD3 overexpression inhibits the above abilities. Also, MBD3 knockdown remarkably increases mesenchymal markers expression of Vimentin, α-SMA, Snail, N-cadherin, β-catenin, and downregulates epithelial markers expression of E-cadherin. On the contrary, MBD3 overexpression results in the opposite effects. Further evidence reveals that MBD3 knockdown up-regulates expression of TGF-β, and then activates p-Smad2 and p-Smad3, while MBD3 overexpression results in downregulation of TGF-β, p-Smad2, and p-Smad3.Conclusions:MBD3 inhibits EMT in pancreatic cancer cells probably via TGF-β/Smad signalling, and may be a new candidate target for diagnostics and prognosis of pancreatic cancer.

[1]  Zhaolan Zhou,et al.  Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation , 2016, Front. Genet..

[2]  Neema Jamshidi,et al.  Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGF β‐induced epithelial‐to‐mesenchymal transition , 2016, Cancer medicine.

[3]  M. Lieber,et al.  Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.

[4]  Eun Ryoung Jang,et al.  Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells. , 2005, Cancer research.

[5]  W. McCombs,et al.  Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse. , 1983, Cancer research.

[6]  S. Bader,et al.  Genetic and epigenetic analyses of MBD3 in colon and lung cancer , 2004, British Journal of Cancer.

[7]  C. Heeschen,et al.  DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster. , 2016, Cancer research.

[8]  Ya-jie Wang,et al.  ESC reverses epithelial mesenchymal transition induced by transforming growth factor-β via inhibition of Smad signal pathway in HepG2 liver cancer cells , 2015, Cancer Cell International.

[9]  A. Klein.  Genetic susceptibility to pancreatic cancer , 2012, Molecular carcinogenesis.

[10]  Y. Mo,et al.  MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells , 2016, Oncotarget.

[11]  S. Batra,et al.  Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas , 2016, Oncotarget.

[12]  R. Weinberg,et al.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.

[13]  Z. Chen,et al.  MiR‐134‐Mbd3 axis regulates the induction of pluripotency , 2016, Journal of cellular and molecular medicine.

[14]  Jianguo Song,et al.  Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition. , 2010, The international journal of biochemistry & cell biology.

[15]  H. Elsässer,et al.  Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[16]  M. Kudo,et al.  Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer , 2014, Molecular Cancer.

[17]  Liviu Badea,et al.  Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. , 2008, Hepato-gastroenterology.

[18]  Zhenyu Xu,et al.  Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial–mesenchymal transition and remodeling of actin cytoskeleton organization , 2016, Oncogene.

[19]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[20]  J. Brumbaugh,et al.  Removing reprogramming roadblocks: Mbd3 depletion allows deterministic iPSC generation. , 2013, Cell stem cell.

[21]  R. Artigiani,et al.  Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis , 2014, Tumor Biology.

[22]  A. Wells,et al.  Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer , 2012, Cancer and Metastasis Reviews.

[23]  D. Saur,et al.  E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. , 2009, Gastroenterology.

[24]  D. Koh,et al.  The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation , 2013, Nucleic acids research.

[25]  Tzong-Der Way,et al.  EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells. , 2012, Journal of agricultural and food chemistry.

[26]  N. Lemoine,et al.  Pancreatic Cancer Genetics , 2001, Pancreatology.

[27]  H. Stunnenberg,et al.  MBD2 and MBD3: elusive functions and mechanisms , 2014, Front. Genet..

[28]  R. Cheng,et al.  Human NUMB6 Induces Epithelial‐Mesenchymal Transition and Enhances Breast Cancer Cells Migration and Invasion , 2017, Journal of cellular biochemistry.

[29]  Zohar Mukamel,et al.  Deterministic direct reprogramming of somatic cells to pluripotency , 2013, Nature.

[30]  Katsunori Yoshida,et al.  Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions , 2016, Journal of clinical medicine.

[31]  J. Berlin,et al.  Treatment of metastatic pancreatic adenocarcinoma: a review. , 2014, Oncology.

[32]  B. Bao,et al.  Activated K‐Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype , 2013, Journal of cellular physiology.

[33]  M. Del Chiaro,et al.  Early detection and prevention of pancreatic cancer: is it really possible today? , 2014, World journal of gastroenterology.

[34]  J. Crook,et al.  Repressed by a NuRD , 2006, Nature Cell Biology.